Composition for cancer radiotherapy sensitization and application thereof
Patent Information
- Authority / Receiving Office
- CN Β· China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SUN YAT SEN UNIV CANCER CENT
- Publication Date
- 2020-07-24
- Estimated Expiration
- Not applicable Β· inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of tumors, and in particular relates to a composition for cancer radiosensitization and its application. Background technique
[0002] Chemoradiotherapy, which accounts for a large proportion of current cancer treatment modalities, significantly increases the control rate of local progression and leads to clinical and histological tumor regression. However, because the treatment is limited by indications, contraindications, drug resistance and high-dose side effects, the curative effect is not ideal. Therefore, it has become a current research hotspot to study new therapeutic strategies combined with radiotherapy and chemotherapy to improve the sensitivity of cancer patients. At the same time, it is necessary and urgent to study the mechanism of their combined effects. For example, in the treatment of colorectal cancer, radiotherapy is one of the important methods in the comprehensive treatment of colorectal cancer, ...